Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00687830 · ClinicalTrials.gov registry record · Phase 3
Efficacy of Morning-only Bowel Preparation for Afternoon Colonoscopy.
A Phase 3 study, sponsored by Cleveland Clinic Florida.
- Completed
- Registry status
- Phase 3
- Development phase
- 136
- Enrollment target
NCT00687830: Completed Phase 3 study, sponsored by Cleveland Clinic Florida.
NCT00687830 is a Phase 3 study that has completed, run by Cleveland Clinic Florida. The registered enrollment target is 136 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00687830, a Phase 3 study, has completed, sponsored by Cleveland Clinic Florida.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 136 participants
- Enrollment target
Study Summary
The study aims to study the adequacy of bowel preparation (colon cleansing) for afternoon colonoscopies. The conventional regimen of giving bowel prep on the evening prior to the day of the colonoscopy will be compared with that given on the morning of an afternoon colonoscopy. Endoscopist scoring the bowel cleansing efficacy with an Ottawa Scale are blinded to the randomization process.
Interventions
- DRUG Polyethylene Glycol afternoon
- DRUG Polyethylene Glycol morning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-11 |
| Phase | Phase 3 |
What the finished NCT00687830 record still lists
NCT00687830 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Polyethylene Glycol afternoon is the first listed.
NCT00687830 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00687830 about?
NCT00687830 is a clinical study titled "Efficacy of Morning-only Bowel Preparation for Afternoon Colonoscopy.". The study aims to study the adequacy of bowel preparation (colon cleansing) for afternoon colonoscopies. The conventional regimen of giving bowel prep on the evening prior to the day of the colonoscopy will be compared with that given on the morning of an afternoon colonoscopy. Endoscopist scoring t...
What is the current status of trial NCT00687830?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 136 participants. The study started on 2008-02. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00687830?
The interventions under investigation include: Polyethylene Glycol afternoon (DRUG), Polyethylene Glycol morning (DRUG).
Who is sponsoring clinical trial NCT00687830?
This trial is sponsored by Cleveland Clinic Florida, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00687830's enrollment target sits among peer trials
136 1580th of 2000 higher than 419 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia